Mediwound announces positive initial data from its u.s. phase 2 pharmacology study of escharex showing effective and rapid debridement in chronic and hard to heal wounds

Data demonstrate escharex reduces biofilm and bacterial burden escharex is shown to be safe with no observed safety issues
MDWD Ratings Summary
MDWD Quant Ranking